Clinical Trial Update: Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating panitumumab for platinum-resistant advanced head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Southern Europe New Drug Organization | Conditions: Advanced Head and Neck Squamous Cancer | Phase 2 | Status: COMPLETED